CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 44.247
EU - Europa 19.846
AS - Asia 6.668
OC - Oceania 79
SA - Sud America 73
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 45
Totale 71.018
Nazione #
US - Stati Uniti d'America 43.400
CN - Cina 3.853
IT - Italia 3.689
DE - Germania 3.631
SE - Svezia 3.207
IE - Irlanda 3.155
UA - Ucraina 2.405
HK - Hong Kong 1.272
GB - Regno Unito 1.078
CA - Canada 825
FI - Finlandia 604
RU - Federazione Russa 489
VN - Vietnam 485
AT - Austria 447
FR - Francia 349
IN - India 282
DK - Danimarca 261
TR - Turchia 182
NL - Olanda 154
JP - Giappone 152
KR - Corea 139
BE - Belgio 114
SG - Singapore 106
AU - Australia 59
IR - Iran 56
EU - Europa 53
BR - Brasile 45
PL - Polonia 43
MY - Malesia 36
ES - Italia 33
RO - Romania 27
CH - Svizzera 22
TW - Taiwan 22
NZ - Nuova Zelanda 20
GR - Grecia 19
HR - Croazia 19
PT - Portogallo 19
CZ - Repubblica Ceca 18
EG - Egitto 16
BG - Bulgaria 12
NO - Norvegia 12
MX - Messico 11
RS - Serbia 11
ID - Indonesia 10
PK - Pakistan 10
SC - Seychelles 10
CL - Cile 9
PH - Filippine 9
TH - Thailandia 9
IQ - Iraq 8
PE - Perù 8
ZA - Sudafrica 8
IL - Israele 7
SA - Arabia Saudita 6
AR - Argentina 5
LB - Libano 5
LU - Lussemburgo 5
MD - Moldavia 5
SI - Slovenia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
GT - Guatemala 4
HU - Ungheria 4
MU - Mauritius 4
A1 - Anonimo 3
BD - Bangladesh 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
BH - Bahrain 2
CO - Colombia 2
JM - Giamaica 2
KW - Kuwait 2
MN - Mongolia 2
MT - Malta 2
TT - Trinidad e Tobago 2
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MM - Myanmar 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TZ - Tanzania 1
Totale 71.018
Città #
Ann Arbor 9.449
Woodbridge 4.641
Fairfield 3.560
Houston 3.427
Dublin 3.064
Chandler 2.845
Jacksonville 2.526
Wilmington 2.277
Frankfurt am Main 2.271
Ashburn 2.030
Dearborn 1.763
Seattle 1.375
Princeton 1.244
Hong Kong 1.234
New York 1.224
Milan 1.188
Cambridge 1.182
Nanjing 713
Lawrence 459
Altamura 448
Hangzhou 447
Vienna 430
Lachine 413
Beijing 411
Shanghai 403
Dong Ket 256
Boardman 241
Guangzhou 236
Nanchang 218
Andover 204
San Diego 199
Toronto 192
Shenyang 191
Helsinki 163
Hebei 154
Falls Church 134
Tianjin 120
Jiaxing 116
Ottawa 116
Changsha 113
Grafing 112
Kazan 112
Fremont 110
Jinan 108
Brussels 101
Mountain View 100
Rome 98
Norwalk 88
Huizen 85
London 83
Detroit 78
Los Angeles 74
Pune 74
Kunming 72
Ningbo 71
Zhengzhou 62
Nürnberg 58
Carate Brianza 56
Hefei 53
Edmonton 50
San Mateo 47
Chicago 44
Redmond 43
Washington 41
Leawood 38
Daejeon 37
Tokyo 37
Taizhou 32
Lissone 31
Sacramento 31
Kiev 29
Auburn Hills 28
Saint Petersburg 27
Turin 27
University Park 27
Bergamo 26
Phoenix 26
Bologna 25
Kocaeli 24
Mainz 24
Shangdi 22
Sydney 22
Philadelphia 21
Fuzhou 20
Kraków 20
Omegna 20
Paris 20
Chengdu 19
Florence 19
Sesto San Giovanni 19
Tappahannock 19
Pavia 18
Perugia 18
Wuhan 18
Brescia 17
Codroipo 17
Haikou 17
Lanzhou 17
Naples 17
Catania 16
Totale 54.342
Nome #
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 418
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 403
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 336
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 321
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 301
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 293
Age-related changes in the function and structure of the peripheral sensory pathway in mice 286
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 280
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 276
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 276
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 274
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 273
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 266
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 260
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 259
Malattie del Sistema Nervoso 258
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 257
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 254
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 253
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 253
The Italian multiple sclerosis register 250
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 246
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 245
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 237
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 235
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 235
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 232
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 232
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 229
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 223
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 222
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 221
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 220
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 218
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 214
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 213
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 213
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 211
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 208
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 208
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 207
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 205
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 202
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y 201
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 201
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 200
Are sigma receptor modulators a weapon against multiple sclerosis disease? 198
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 194
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 192
Role of MAPKs in platinum-induced neuronal apoptosis 191
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 190
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 188
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 186
Enhanced brain targeting of engineered solid lipid nanoparticles 186
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline 185
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 185
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis 180
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 178
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 177
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 177
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 177
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 175
Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells 174
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 174
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 174
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 172
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 170
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 169
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 169
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 169
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 169
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 169
Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study 168
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 168
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 168
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 168
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 167
NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy 167
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 166
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 165
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 164
Pain in chemotherapy-induced peripheral neurotoxicity 164
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 164
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 164
Women with pregnancy-related polymyositis and high serum CK levels in the newborn 163
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases 163
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 162
Malattie del Sistema Nervoso 162
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 162
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 161
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 161
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 161
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 161
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 161
Topology of two DBI receptors in human lymphocytes 160
Ultrastructural organization of lamina VI of the spinal cord of the cat. 160
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 159
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 159
The Italian neuromuscular registry: A coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage 159
Neurotoxicity and photon activation therapy effect of new heavy metal-based anticancer complexes 159
Totale 20.759
Categoria #
all - tutte 214.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.719 0 0 0 0 0 0 0 0 0 0 1.296 1.423
2019/202014.142 1.764 859 982 1.005 1.333 1.723 2.088 994 1.315 900 898 281
2020/202111.730 705 487 1.422 1.222 840 908 1.351 1.075 1.006 1.072 606 1.036
2021/20227.268 464 759 732 672 492 676 355 400 350 499 561 1.308
2022/202312.644 1.552 3.530 1.184 1.077 893 1.970 170 657 896 141 314 260
2023/20248.840 335 389 450 424 1.434 2.369 1.959 439 786 247 8 0
Totale 74.772